Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Lexicon Pharmaceutcl (LXRX)

Lexicon Pharmaceutcl (LXRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 346,447
  • Shares Outstanding, K 106,272
  • Annual Sales, $ 63,210 K
  • Annual Income, $ -120,550 K
  • 60-Month Beta 0.91
  • Price/Sales 5.57
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 1.31
  • Number of Estimates 2
  • High Estimate 1.49
  • Low Estimate 1.12
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +603.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.80 +14.29%
on 10/01/19
3.85 -16.88%
on 09/19/19
-0.60 (-15.79%)
since 09/18/19
3-Month
1.13 +184.44%
on 08/02/19
5.76 -44.44%
on 07/26/19
-2.13 (-39.96%)
since 07/18/19
52-Week
1.13 +184.44%
on 08/02/19
9.33 -65.70%
on 11/08/18
-5.45 (-63.01%)
since 10/18/18

Most Recent Stories

More News
SmarTrend Watching for Potential Pullback in Shares of Lexicon Pharmace After 8.09% Gain

Lexicon Pharmace (NASDAQ:LXRX) traded in a range yesterday that spanned from a low of $3.28 to a high of $3.77. Yesterday, the shares gained 8.1%, which took the trading range above the 3-day high of...

LXRX : 3.20 (-1.84%)
Lexicon Pharmaceuticals Announces Poster Presentations at the NANETS Annual Multidisciplinary NET Medical Symposium

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that data from five posters highlighting XERMELO(telotristat ethyl) will be presented at the upcoming North American Neuroendocrine Tumor Society...

LXRX : 3.20 (-1.84%)
Small Caps Win in September: 5 Best ETFs & Stocks

We highlight five small-cap ETFs and stocks that have outperformed in September. These could be excellent plays for investors should the same trends prevail.

HOV : 26.86 (+6.21%)
RWJ : 63.32 (-0.65%)
PSCM : 43.86 (-0.32%)
RZV : 63.32 (-0.71%)
KOOL : 5.46 (+2.25%)
LXRX : 3.20 (-1.84%)
MCF : 2.49 (+14.75%)
YI : 4.70 (-3.09%)
XSVM : 30.53 (-0.29%)
XSHD : 24.06 (-0.24%)
Are Options Traders Betting on a Big Move in Lexicon Pharmaceuticals (LXRX) Stock?

Investors need to pay close attention to Lexicon Pharmaceuticals (LXRX) stock based on the movements in the options market lately.

LXRX : 3.20 (-1.84%)
Look for Shares of Lexicon Pharmace to Potentially Pullback after Yesterday's 22.11% Rise

Lexicon Pharmace (NASDAQ:LXRX) traded in a range yesterday that spanned from a low of $2.31 to a high of $3.67. Yesterday, the shares gained 22.1%, which took the trading range above the 3-day high of...

LXRX : 3.20 (-1.84%)
Lexicon (LXRX) Catches Eye: Stock Jumps 7.3%

Lexicon (LXRX) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

ACOR : 2.46 (-4.65%)
LXRX : 3.20 (-1.84%)
Traders Get Bullish on Shares of Lexicon Pharmace, Shares Up 45.3% (LXRX)

Lexicon Pharmace (NASDAQ:LXRX) is one of today's best performing low-priced stocks, up 45.3% to $2.50 on 2.5x average daily volume. Lexicon Pharmace has traded 5.5 million shares thus far today, vs. average...

LXRX : 3.20 (-1.84%)
Lexicon (LXRX) Settles With Sanofi for $260M, Shares Rally

Lexicon Pharmaceuticals (LXRX) settles with Sanofi related to termination of their alliance for development of Zynquista in type I and type II diabetes.

AZN : 43.87 (-0.59%)
JNJ : 127.70 (-6.22%)
SNY : 46.17 (-0.71%)
LXRX : 3.20 (-1.84%)
Lexicon Pharmaceuticals to Present Sotagliflozin Clinical Data at the European Association for the Study of Diabetes 55th Annual Meeting

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced that clinical data for Zynquista (sotagliflozin) will be presented at the upcoming European Association for the Study of Diabetes (EASD) 55...

LXRX : 3.20 (-1.84%)
Lexicon Pharmaceuticals Announces Termination of Alliance and Settlement With Sanofi

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced the termination of its alliance with Sanofi for the development and commercialization of Zynquista (sotagliflozin) and the settlement of its...

LXRX : 3.20 (-1.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade LXRX with:

Business Summary

Lexicon Genetics Incorporated is a leader in defining the functions of genes for drug discovery using large-scale knockout mouse technology. Lexicon has invented high-throughput gene trapping technology to discover thousands of genes and expand its OmniBank library of tens of thousands of mouse clones....

See More

Key Turning Points

2nd Resistance Point 3.39
1st Resistance Point 3.30
Last Price 3.20
1st Support Level 3.13
2nd Support Level 3.05

See More

52-Week High 9.33
Fibonacci 61.8% 6.20
Fibonacci 50% 5.23
Fibonacci 38.2% 4.26
Last Price 3.20
52-Week Low 1.13

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar